Cytoskeletal effects induced by Pet, the serine protease enterotoxin of enteroaggregative Escherichia coli

Citation
F. Navarro-garcia et al., Cytoskeletal effects induced by Pet, the serine protease enterotoxin of enteroaggregative Escherichia coli, INFEC IMMUN, 67(5), 1999, pp. 2184-2192
Citations number
45
Categorie Soggetti
Immunology
Journal title
INFECTION AND IMMUNITY
ISSN journal
00199567 → ACNP
Volume
67
Issue
5
Year of publication
1999
Pages
2184 - 2192
Database
ISI
SICI code
0019-9567(199905)67:5<2184:CEIBPT>2.0.ZU;2-N
Abstract
We have previously described enteroaggregative Escherichia coli (EAEC) stra ins that induce cytotoxic effects on T84 cells, ligated rat ileal loops, an d human intestine in culture. Such strains secrete a 104-kDa protein termed Pet (for plasmid-encoded toxin), We have also shown previously that the Pe t toxin induces rises in short-circuit current and decreases the electrical resistance in rat jejunum mounted in an Ussing chamber. The nucleotide seq uence of the pet gene revealed that Pet is a member of the autotransporter class of secreted proteins. Here we show that a concentrated supernatant of E. coli HB101 harboring the minimal pet clone pCEFN1 induces temperature-, time- and dose-dependent cytopathic effects on HEp-2 cells and HT29 C-1 ce lls in culture. The effects were characterized by release of the cellular f ocal contacts from the glass substratum, followed by complete rounding of t he cells and detachment from the glass. Staining of the Pet-treated cells w ith Live/Dead viability stain revealed that >90% of rounded cells were viab le. Pet-intoxicated HEp-2 and HT29 cells stained with fluorescein-labeled p halloidin revealed contraction of the cytoskeleton and loss of actin stress fibers. However, the effects of Pet were not inhibited by cytoskeleton-alt ering drugs, including colchicine, taxol, cytochalasin D, and phallicidin, The Pet protein induced proteolysis in zymogram gels, and preincubation wit h the serine protease inhibitor phenylmethylsulfonyl fluoride resulted in c omplete abrogation of Pet cytopathic effects. We introduced a mutation in a predicted catalytic serine residue and found that the mutant (Pet S260I) w as deficient in protease activity and did not produce cytopathic effects, c ytoskeletal damage, or enterotoxic effects in Ussing chambers. These data s uggest that Pet is a cytoskeleton altering toxin and that its protease acti vity is involved in each of the observed phenotypes.